Xtandi 40 mg Soft Capsule

Xtandi 40 mg Soft Capsule contains enzalutamide, a targeted anticancer medicine used for prostate cancer. Each soft capsule contains 40 mg of enzalutamide and is taken orally as prescribed by a healthcare professional. It works by blocking androgen receptor signals that can promote the growth of prostate cancer cells.

BUY NOW

Category Astellas Pharma Inc

Description

Enzalutamide is an androgen receptor inhibitor that interferes with hormone signaling involved in the growth and survival of prostate cancer cells. Xtandi may be used for different stages of prostate cancer, including metastatic hormone-sensitive and castration-resistant disease, according to the approved clinical indication. The medicine can be used alone or with androgen deprivation therapy depending on the patient’s treatment plan. Treatment should be initiated and monitored by a qualified healthcare professional experienced in oncology care.

Technical Specification

Specification	Details
Active Ingredient	Enzalutamide
Strength	40 mg
Dosage Form	Soft Capsule
Route of Administration	Oral
Pack Size	Bottle of 112 Soft Capsules
Storage	Store below 30°C

Product Also Known As

Xtandi 40 mg Soft Capsule, Enzalutamide 40 mg Capsule, Xtandi Enzalutamide Capsule, Enzalutamide Prostate Cancer Capsule, Androgen Receptor Inhibitor Capsule, Prostate Cancer Treatment Capsule